ALVOGEN PHARMA US INC is a security (CUSIP 02254GAF0) tracked across SEC portfolio filings. 1 registered fund positions totaling $422K via N-PORT as of 2024-08-31.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | $422K | 30.54% |